Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$5,716,757
+$692,521 QoQ
Shares Held
22,718
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#1,237
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WOODMONT INVESTMENT COUNSEL LLC holds $91,634,066 across 9 Drug Manufacturers - General names. ABBV ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,183 | $26,606,957 | |
| 2 | JNJ |
Johnson & Johnson
|
92,061 | $23,380,732 | |
| 3 | MRK |
Merck & Co., Inc.
|
173,179 | $22,253,501 | |
| 4 | PFE |
Pfizer Inc
|
284,542 | $6,851,771 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
22,718 | $5,716,757 | |
| 6 | NVS |
Novartis AG
|
27,118 | $4,249,932 | |
| 7 | NVO |
Novo Nordisk A S
|
27,438 | $1,315,377 | |
| 8 | AMGN |
Amgen Inc
|
1,805 | $653,626 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,716,757 | 22,718 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,024,236 | 23,101 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $5,312,392 | 23,250 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $5,409,932 | 23,365 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,324,946 | 23,300 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $4,874,063 | 23,263 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $4,169,375 | 23,463 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,930,680 | 24,968 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $4,393,999 | 25,618 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $4,690,531 | 25,758 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $4,028,135 | 25,993 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $4,010,161 | 26,903 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $3,694,431 | 27,421 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $4,477,181 | 28,093 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $4,373,489 | 27,062 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $3,620,448 | 26,976 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,947,545 | 25,774 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,068,312 | 25,096 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,276,138 | 24,196 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,630,409 | 24,385 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,759,004 | 24,494 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,464,385 | 22,772 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,279,401 | 21,273 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,631,188 | 18,623 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,740,535 | 17,728 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,417,362 | 18,603 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||